Undisclosed Regenerative Medicine Program
Tissue Repair
Pre-clinicalActive
Key Facts
About CTC
CTC is a European biotech pioneer in the cell therapy space, with over two decades of experience developing regenerative treatments. The company leverages its expertise in culturing both patient-derived (autologous) and donor-derived (allogeneic) cells to create therapies aimed at repairing damaged tissues. While specific pipeline details are not publicly disclosed, its focus on oncology and regenerative medicine places it in high-growth therapeutic areas. As a private company, its progress is likely tied to strategic partnerships and non-dilutive funding to advance its programs toward clinical validation.
View full company profile